United Kingdom set to approve Covid-19 vaccine


Jobs dosage may begin in the spring, but it may not be approved by the Medicines and Healthcare Products Regulatory Authority (MHRA). Vaccine orders have also been placed with other manufacturers.

Fearne told MaltaToday in an interview published today that Malta has half-a-million coronavirus vaccine doses ordered from Pfizer and the first batch could be expected to arrive here in January.

Unlike traditional vaccine rollouts, Pfizer plans to bypass distribution wholesalers, including McKesson Corp., which has been tapped by the USA government to distribute other Covid-19 vaccines through the federal "Operation Warp Speed" program.

It has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University and has targeted a rollout to begin before Christmas.

The NHS workers will be the first ones to receive the vaccination in Britain.

On 16 November, Moderna published initial data showing that its candidate is almost 95% effective in protecting against COVID-19, with no safety issues identified to date. Pfizer and BioNTech started conducting Phase 3 trials of their experimental vaccine by July.

Lukashenko: I will resign once Belarus adopts new constitution
More than three months after an historic protest movement emerged across Belarus, people continue to take to the streets. Protests against the president are taking place in several cities, including the Razdhani Minsk , nearly daily.

According to the statement, the new deal, signed on Sunday, brings the total number of Moderna vaccine doses secured for the United Kingdom to 7 million. Health minister Matt Hancock made a statement.

The government asked the regulator on Friday to assess AstraZeneca Plc's COVID-19 vaccine for a possible rollout.

"A big responsibility and a big operational challenge but we are absolutely committed to ensuring that vaccines can be implemented quickly to save lives and livelihoods".

"The modern vaccine has been a significant addition to our portfolio and the additional two million doses of protection further enhance the protection we can give the public to end the epidemic".

Once they have thoroughly reviewed the data, the MHRA will seek advice from the government's independent advisory body, the Commission on Human Medicines.